We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

688256:SSECambricon Technologies Corp. Ltd. Class A Analysis

Data as of 2026-06-10 - not real-time

CN¥1,231.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Cambricon Technologies (688256) is trading at CNY 1,231, comfortably above its technical support of CNY 1,175 but below the 20‑day SMA of CNY 1,306, indicating a short‑term pull‑back within a broader bullish framework (20‑day SMA > 50‑day SMA > 200‑day SMA). The RSI sits at 49.7, signaling a neutral momentum, while the MACD histogram is negative and the signal line is bearish, suggesting limited upside in the near term. Volatility is extremely high at ~88% over the past 30 days, and volume is on a decreasing trend, which could amplify price swings. Fundamentally, the company boasts strong profitability (gross margin 53%, operating margin 43%, profit margin 33%) and robust cash generation (CNY 6.19 bn cash, low debt), but valuation metrics are stretched: a trailing PE of 286 versus an industry average of 35, a price‑to‑book of 60, and a DCF fair value of only CNY 26.8. The dividend yield is negligible at 0.12% with a zero payout ratio, indicating limited income appeal. In summary, the stock’s fundamentals are solid, yet it is severely overvalued, with high volatility and bearish short‑term technical signals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below 20‑day SMA indicating short‑term weakness
  • Bearish MACD histogram and decreasing volume
  • High 30‑day volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Sustained bullish SMA hierarchy (20 > 50 > 200)
  • Strong margins and cash position
  • Valuation remains far above fair value

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Secular growth in AI‑chip demand in China
  • Robust profitability and low leverage
  • Potential valuation correction as market re‑prices fundamentals

Key Metrics & Analysis

Financial Health

Revenue Growth159.60%
Profit Margin32.85%
P/E Ratio285.6
ROE29.03%
ROA14.93%
Debt/Equity0.13
P/B Ratio60.1
Op. Cash FlowCN¥1.7B
Free Cash FlowCN¥298.6M
Industry P/E35.2

Technical Analysis

TrendBullish
RSI49.7
SupportCN¥1,175.00
ResistanceCN¥1,448.01
MA 20CN¥1,306.48
MA 50CN¥1,070.76
MA 200CN¥909.00
MACDBearish
VolumeDecreasing
Fear & Greed Index81.75

Valuation

Fair ValueCN¥26.83
GradeOvervalued
TypeGrowth
Dividend Yield0.12%

Risk Assessment

Beta0.68
Volatility88.00%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.